Timothy Coughlin - Jun 9, 2022 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role
Director
Signature
/s/ Cindy Tahl, as Attorney-in-Fact
Stock symbol
FATE
Transactions as of
Jun 9, 2022
Transactions value $
$0
Form type
4
Date filed
6/13/2022, 04:39 PM
Previous filing
Jun 6, 2022
Next filing
Apr 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FATE Common Stock Award $0 +8.65K +696.46% $0.00 9.89K Jun 9, 2022 Direct F1
holding FATE Common Stock 56.4K Jun 9, 2022 By Coughlin Family Trust u/a DTD 12/07/2006 F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FATE Stock Option (Right to Buy) Award $0 +11.9K $0.00 11.9K Jun 9, 2022 Common Stock 11.9K $23.48 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of restricted stock units that vest in full on the earlier of (i) June 9, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors.
F2 56,390 shares were transferred by the Reporting Person to the Coughlin Family Trust u/a DTD 12/07/2006 in 2017.
F3 These shares are owned of record by Coughlin Family Trust u/a DTD 12/07/2006 for which the Reporting Person and his spouse Holly Coughlin serve as co-trustees, and the Reporting Person may be deemed to be the beneficial owner of the securities held by the Coughlin Family Trust u/a DTD 12/07/2006.
F4 The shares subject to this option shall vest and become exercisable on the earlier of (i) June 9, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors.